1-15 of 15
Authors: Norio Nonomura
Sort by
Journal Article
Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study Open Access
Akira Nagahara and others
Japanese Journal of Clinical Oncology, Volume 54, Issue 5, May 2024, Pages 584–591, https://doi.org/10.1093/jjco/hyae004
Published: 01 February 2024
Journal Article
Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients Free
Ukihide Tateishi and others
Japanese Journal of Clinical Oncology, Volume 54, Issue 3, March 2024, Pages 282–291, https://doi.org/10.1093/jjco/hyad166
Published: 08 December 2023
Journal Article
The safety profile of nivolumab plus ipilimumab combination therapy in Japanese patients with renal cell carcinoma: results from post-marketing surveillance Open Access
Hirotsugu Uemura and others
Japanese Journal of Clinical Oncology, Volume 53, Issue 8, August 2023, Pages 730–737, https://doi.org/10.1093/jjco/hyad034
Published: 06 May 2023
Journal Article
Risk factors for recurrence after operation in patients with pT1a renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association Free
Nobuyuki Nakajima and others
Japanese Journal of Clinical Oncology, Volume 52, Issue 3, March 2022, Pages 274–280, https://doi.org/10.1093/jjco/hyab201
Published: 06 January 2022
Journal Article
Corrigendum to: Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program Free
Haruki Kume and others
Japanese Journal of Clinical Oncology, Volume 49, Issue 11, November 2019, Page 1067, https://doi.org/10.1093/jjco/hyz143
Published: 06 November 2019
Journal Article
Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program
Get access
Haruki Kume and others
Japanese Journal of Clinical Oncology, Volume 49, Issue 8, August 2019, Pages 772–779, https://doi.org/10.1093/jjco/hyz054
Published: 12 April 2019
Journal Article
Active heavy cigarette smoking is associated with poor survival in Japanese patients with advanced renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association
Get access
Tomohiko Hara and others
Japanese Journal of Clinical Oncology, Volume 47, Issue 12, December 2017, Pages 1162–1169, https://doi.org/10.1093/jjco/hyx129
Published: 08 November 2017
Journal Article
Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association
Get access
Takuya Koie and others
Japanese Journal of Clinical Oncology, Volume 46, Issue 5, May 2016, Pages 468–474, https://doi.org/10.1093/jjco/hyw005
Published: 19 May 2016
Journal Article
Adverse Event Profile and Dose Modification of Everolimus for Advanced Renal Cell Carcinoma in Real-world Japanese Clinical Practice
Get access
Masahiro Nozawa and others
Japanese Journal of Clinical Oncology, Volume 43, Issue 11, November 2013, Pages 1132–1138, https://doi.org/10.1093/jjco/hyt121
Published: 01 September 2013
Journal Article
Solitary Skin Metastasis Adjacent to Ureterocutaneostomy 4 Years After Radical Cystectomy for Bladder Cancer
Get access
Takahiro Yoshida and others
Japanese Journal of Clinical Oncology, Volume 42, Issue 4, April 2012, Pages 331–334, https://doi.org/10.1093/jjco/hys017
Published: 02 March 2012
Journal Article
Clinical Outcome and Prognostic Factors of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma in General Clinical Practice
Get access
Go Tanigawa and others
Japanese Journal of Clinical Oncology, Volume 41, Issue 11, November 2011, Pages 1265–1270, https://doi.org/10.1093/jjco/hyr137
Published: 29 September 2011
Journal Article
Retrospective Analysis of an Oral Combination of Dexamethasone, Uracil plus Tegafur and Cyclophosphamide for Hormone-refractory Prostate Cancer
Get access
Koji Hatano and others
Japanese Journal of Clinical Oncology, Volume 41, Issue 2, February 2011, Pages 253–259, https://doi.org/10.1093/jjco/hyq178
Published: 10 November 2010
Journal Article
Overall Survival and Updated Results from a Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma
Get access
Yoshihiko Tomita and others
Japanese Journal of Clinical Oncology, Volume 40, Issue 12, December 2010, Pages 1166–1172, https://doi.org/10.1093/jjco/hyq146
Published: 16 August 2010
Journal Article
Tumor Multiplicity is an Independent Prognostic Factor of Non-muscle-invasive High-grade (T1G3) Bladder Cancer
Get access
Yasutomo Nakai and others
Japanese Journal of Clinical Oncology, Volume 40, Issue 3, March 2010, Pages 252–257, https://doi.org/10.1093/jjco/hyp159
Published: 07 December 2009
Journal Article
A Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma: Insights into the Treatment, Efficacy and Safety
Get access
Hirotsugu Uemura and others
Japanese Journal of Clinical Oncology, Volume 40, Issue 3, March 2010, Pages 194–202, https://doi.org/10.1093/jjco/hyp146
Published: 07 November 2009
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals